VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / RepliCel Life Sciences Inc. (TSX.V:RP) (OTCPK:REPCF) (FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in ...
The number of people who live with diabetes is on the rise. By estimates of the World Health Organization (WHO), one in eleven people are affected by the disease. This makes the auto-injector market ...
The latest version of Instron’s Autoinjector Testing System was developed in close collaboration with CDMOs and pharmaceutical device manufacturers. It can perform thorough functioning testing on ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
Instron’s CT6 can be configured as an automated solution for the required testing of auto-injection devices – providing the benefits of automation without the additional complexity of a fully ...
VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / RepliCel Life Sciences Inc. (TSX.V:RP) (OTCPK:REPCF) (FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results